79 related articles for article (PubMed ID: 10527713)
1. Dose-dependent limitation of arterial enlargement by the matrix metalloproteinase inhibitor RS-113,456.
Karwowski JK; Markezich A; Whitson J; Abbruzzese TA; Zarins CK; Dalman RL
J Surg Res; 1999 Nov; 87(1):122-9. PubMed ID: 10527713
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model.
Abbruzzese TA; Guzman RJ; Martin RL; Yee C; Zarins CK; Dalman RL
Surgery; 1998 Aug; 124(2):328-34; discussion 334-5. PubMed ID: 9706156
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression.
Eagleton MJ; Peterson DA; Sullivan VV; Roelofs KJ; Ford JA; Stanley JC; Upchurch GR
J Surg Res; 2002 May; 104(1):15-21. PubMed ID: 11971672
[TBL] [Abstract][Full Text] [Related]
4. Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats.
Chan CY; Chen YS; Ma MC; Chen CF
J Vasc Surg; 2007 Apr; 45(4):804-11. PubMed ID: 17398390
[TBL] [Abstract][Full Text] [Related]
5. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
7. ACE inhibition reduces activity of the plasminogen/plasmin and MMP systems in the brain of spontaneous hypertensive stroke-prone rats.
Liebetrau M; Burggraf D; Wunderlich N; Jäger G; Linz W; Hamann GF
Neurosci Lett; 2005 Mar; 376(3):205-9. PubMed ID: 15721222
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva.
Chiu HC; Lu YT; Chin YT; Tu HP; Chiang CY; Gau CH; Nieh S; Fu E
J Periodontal Res; 2009 Jun; 44(3):338-47. PubMed ID: 19210333
[TBL] [Abstract][Full Text] [Related]
9. Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia.
Liuzzi GM; Mastroianni CM; Latronico T; Mengoni F; Fasano A; Lichtner M; Vullo V; Riccio P
Brain; 2004 Feb; 127(Pt 2):398-407. PubMed ID: 14662518
[TBL] [Abstract][Full Text] [Related]
10. Effect of matrix metalloproteinase inhibition on adipose tissue development.
Demeulemeester D; Collen D; Lijnen HR
Biochem Biophys Res Commun; 2005 Apr; 329(1):105-10. PubMed ID: 15721280
[TBL] [Abstract][Full Text] [Related]
11. Expression and activation of MMP -2, -3, -9, -14 are induced in rat colon after abdominal X-irradiation.
Strup-Perrot C; Vozenin-Brotons MC; Vandamme M; Benderitter M; Mathe D
Scand J Gastroenterol; 2006 Jan; 41(1):60-70. PubMed ID: 16373278
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight inhibitors of matrix metalloproteinases can enhance the expression of matrix metalloproteinase-2 (gelatinase A) without inhibiting its activation.
Kerkvliet EH; Jansen ID; Schoenmaker TA; Docherty AJ; Beertsen W; Everts V
Cancer; 2003 Mar; 97(6):1582-8. PubMed ID: 12627524
[TBL] [Abstract][Full Text] [Related]
13. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
14. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
15. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
Mannello F; Jung K; Tonti GA; Canestrari F
Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
[TBL] [Abstract][Full Text] [Related]
16. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the involvement of matrix metalloproteinases in the cardiovascular effects produced by nicotine.
Jacob-Ferreira AL; Palei AC; Cau SB; Moreno H; Martinez ML; Izidoro-Toledo TC; Gerlach RF; Tanus-Santos JE
Eur J Pharmacol; 2010 Feb; 627(1-3):216-22. PubMed ID: 19879865
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 modulates intestinal injury in rats with transmural colitis.
Medina C; Santana A; Paz MC; Díaz-Gonzalez F; Farre E; Salas A; Radomski MW; Quintero E
J Leukoc Biol; 2006 May; 79(5):954-62. PubMed ID: 16478919
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
